Emcure Pharma's IPO Opens On July 3

Price Band fixed at Rs960 per equity share of face value of Rs10 each to Rs1008 per equity share of the face value of Rs10 each

Akshay Sahai, Jefferies India; V. Jayasankar, Kotak Mahindra Capital Company; Piyush Nahar (EVP, Corporate Development, Strategy & Finance, Emcure Pharmaceutical); Ms. Namita Thapar (Whole-time Director, Emcure Pharmaceuticals); Satish Mehta (MD and CEO, Emcure Pharmaceuticals); Samit Mehta (Whole-time Director, Emcure Pharmaceuticals); Vikas Thapar (President, Corporate Development, Strategy & Finance, Emcure Pharmaceuticals); Tajuddin Shaikh (CFO, Emcure Pharmaceuticals); Kuunal Mallkan, Axis

FinTech BizNews Service 

Mumbai, June 28, 2024: Emcure Pharmaceuticals Limited (the “Company”) proposes to open its initial public offering of Equity Shares (“Offer”) on Wednesday, July 03, 2024. The Anchor Investor Bid/Offer Period is one Working Day prior to Bid/Offer Opening Date, that is, Tuesday, July 02, 2024. Bid/ Offer Closing Date will be on Friday, July 05, 2024.

The Price Band of the Offer has been fixed from Rs 960 per Equity Share to Rs 1008 per Equity Share. Bids can be made for a minimum of 14 Equity Shares and multiples of 14 Equity Shares thereafter.  

The IPO includes a fresh share sale of Rs8 Billion and an offer for sale (OFS) of 1.14 crore equity shares by the promoters and existing shareholders. Emcure Pharmaceuticals is aiming to raise total Rs1951.04 crore through the issue.

The Company proposes to utilize the net proceeds towards repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the Company and general corporate purposes.

The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on both BSE Limited (“BSE") and the National Stock Exchange of India Limited (“NSE”, together with BSE, the “Stock Exchanges”).

Kotak Mahindra Capital Company Limited, Axis Capital Limited, Jefferies India Private Limited, and J.P. Morgan India Private Limited are the Book Running Lead Managers to the Offer.




Cookie Consent

Our website uses cookies to provide your browsing experience and relavent informations.Before continuing to use our website, you agree & accept of our Cookie Policy & Privacy